$DYNT
DYNATRONICS CORP Stock $dynt

$dynt Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000106299324019082 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2024 Q2
Revenue		$7.602M
YoY Change		-18.71%
Cost Of Revenue		$5.621M
YoY Change		-20.22%
Gross Profit		$1.981M
YoY Change		-14.1%
Gross Profit Margin		26.06%
Selling, General & Admin		$2.232M
YoY Change		-12.33%
% of Gross Profit		112.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$2.232M
YoY Change		-12.33%
Operating Profit		-$251.0K
YoY Change		4.8%
Interest Expense		$106.3K
YoY Change		33.46%
% of Operating Profit
Other Income/Expense, Net		-$106.3K
YoY Change		33.46%
Pretax Income		-$357.3K
YoY Change		11.96%
Income Tax		$9.304K
% Of Pretax Income
Net Earnings		-$366.6K	-$687.9K
YoY Change		10.89%	-71.11%
Net Earnings / Revenue		-4.82%
Basic Earnings Per Share		-$0.09
Diluted Earnings Per Share		-$0.09
COMMON SHARES
Basic Shares Outstanding	7.256M shares	5.896M shares	5.309M shares
Diluted Shares Outstanding		5.890M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$278.4K	$483.9K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$5.471M	$5.594M
Prepaid Expenses	$461.9K	$530.4K
Receivables	$3.056M	$3.445M
Other Receivables	$513.2K	$454.4K
Total Short-Term Assets	$9.831M	$10.56M
YoY Change	-25.66%	-14.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.812M	$1.969M
YoY Change	-21.8%	-19.56%
Goodwill	$7.117M	$7.117M
YoY Change	0.0%	0.0%
Intangibles	$2.845M	$3.000M
YoY Change	-17.85%	-17.09%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$15.23M	$15.38M
YoY Change	-11.03%	-12.81%
TOTAL ASSETS
Total Short-Term Assets	$9.831M	$10.56M
Total Long-Term Assets	$15.23M	$15.38M
Total Assets	$25.06M	$25.94M
YoY Change	-17.41%	-13.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.739M	$2.712M
YoY Change	-29.28%	-40.13%
Accrued Expenses	$516.7K	$725.7K
YoY Change	-51.59%	-18.59%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.296M	$7.705M
YoY Change	-18.05%	-2.97%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities	$185.8K	$189.9K
YoY Change	-7.13%	-5.88%
Total Long-Term Liabilities	$185.8K	$189.9K
YoY Change	-7.13%	-5.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.296M	$7.705M
Total Long-Term Liabilities	$185.8K	$189.9K
Total Liabilities	$11.27M	$11.78M
YoY Change	-18.35%	-10.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$29.44M	-$28.91M
YoY Change	13.21%	13.46%
Common Stock	$35.26M	$35.09M
YoY Change	1.98%	2.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.79M	$14.16M
YoY Change
Total Liabilities & Shareholders Equity	$25.06M	$25.94M
YoY Change	-17.41%	-13.71%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$366.6K	-$687.9K
YoY Change	10.89%	-71.11%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$100.6K
YoY Change	-106.04%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$306.1K
YoY Change	-117.66%
NET CHANGE
Cash From Operating Activities	$100.6K
Cash From Investing Activities	$0.00
Cash From Financing Activities	-$306.1K
Net Change In Cash	-$205.5K
YoY Change	-706.26%
FREE CASH FLOW
Cash From Operating Activities	$100.6K
Capital Expenditures	$0.00
Free Cash Flow	$100.6K
YoY Change	-105.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Amendment Flag AmendmentFlag	false
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55121
CY2024Q3	dei	City Area Code CityAreaCode	801
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	5687000
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock, no par value
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	725727	usd
CY2024Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	117173	usd
CY2024Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	120677	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1181581	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1004808	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7296316	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7704910	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1354738	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1428870	usd
CY2024Q3	dynt	Deferred Gain Net Of Current Portion DeferredGainNetOfCurrentPortion	589254	usd
CY2024Q2	dynt	Deferred Gain Net Of Current Portion DeferredGainNetOfCurrentPortion	626866	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1843528	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1829608	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	185810	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	189861	usd
CY2024Q3	us-gaap	Liabilities Liabilities	11269646	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2845400	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2999975	usd
CY2024Q3	us-gaap	Goodwill Goodwill	7116613	usd
CY2024Q2	us-gaap	Goodwill Goodwill	7116614	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	435203	usd
CY2024Q2	us-gaap	Other Assets OtherAssets	465505	usd
CY2024Q3	us-gaap	Assets Assets	25064642	usd
CY2024Q2	us-gaap	Assets Assets	25940559	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2738921	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2712142	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	398771	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	566443	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	516745	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	7980788	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	13794996	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	14160444	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25940559	usd
CY2024Q3	us-gaap	Revenues Revenues	7602249	usd
CY2023Q3	us-gaap	Revenues Revenues	9351914	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	5621442	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	7045847	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1980807	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	2306067	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2231803	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2545556	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-79683	usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3351000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3351000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3351000	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	7980788	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25064642	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-250996	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-239489	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	106348	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	79683	usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5890394	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5890394	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4261593	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4261593	shares
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-319172	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9304	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11482	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-366648	usd
CY2024Q3	dynt	Amortization Of Deferred Gain On Sale Leaseback AmortizationOfDeferredGainOnSaleLeaseback	37612	usd
CY2023Q3	dynt	Amortization Of Deferred Gain On Sale Leaseback AmortizationOfDeferredGainOnSaleLeaseback	37612	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-9664	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	798308	usd
CY2024Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-30302	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-357430	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-872044	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	100646	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1665272	usd
CY2024Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34607	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-34607	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-306121	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1733771	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-205475	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	33892	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	155245	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	165777	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	154575	usd
CY2024Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2024Q3	us-gaap	Inventory Write Down InventoryWriteDown	-18900	usd
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown	31492	usd
CY2023Q3	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-5631	usd
CY2024Q3	dynt	Dividend Rate DividendRate	0.08	pure
CY2024Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1677	usd
CY2024Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1359299	shares
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	3596287	usd
CY2024Q3	dynt	Allowance For Sales Discounts AllowanceForSalesDiscounts	13420	usd
CY2024Q2	dynt	Allowance For Sales Discounts AllowanceForSalesDiscounts	13814	usd
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	Dynatronics Corporation
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	278443	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	483918	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2121667	usd
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3351000	shares
CY2024Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5308519	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	35256763	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	35087825	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29442555	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-28908169	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-357344	usd
CY2024Q3	dynt	Preferred Stock Dividend In Common Stock Issued To Be Issued PreferredStockDividendInCommonStockIssuedToBeIssued	-167738	usd
CY2023Q3	dynt	Preferred Stock Dividend In Common Stock Issued To Be Issued PreferredStockDividendInCommonStockIssuedToBeIssued	-197059	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-527713	usd
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	16856526	usd
CY2023Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	19173	usd
CY2023Q3	dynt	Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount PreferredStockDividendInCommonStockIssuedOrToBeIssuedAmount	0	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-330654	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	16545045	usd
CY2023Q4	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-3848	usd
CY2023Q4	dynt	Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount PreferredStockDividendInCommonStockIssuedOrToBeIssuedAmount	0	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-1011416	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	15529781	usd
CY2024Q1	dynt	Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount PreferredStockDividendInCommonStockIssuedOrToBeIssuedAmount	0	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	14845567	usd
CY2024Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	2804	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-366648	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2831417	usd
CY2024Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1889715	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	302962	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-534386	usd
CY2024Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-16492	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	14160444	usd
CY2024Q3	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	1200	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-330654	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-366648	usd
CY2024Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	74169	usd
CY2023Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	70135	usd
CY2023Q3	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1803906	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	534328	usd
CY2024Q3	dynt	Preferred Stock Dividend In Common Stock Issued Or To Be Issued PreferredStockDividendInCommonStockIssuedOrToBeIssued	167738	usd
CY2023Q3	dynt	Preferred Stock Dividend In Common Stock Issued Or To Be Issued PreferredStockDividendInCommonStockIssuedOrToBeIssued	197059	usd
CY2023Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	35181	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	19173	usd
CY2024Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	464866	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	3685853	usd
CY2024Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1889715	usd
CY2024Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2121667	usd
CY2024Q3	dynt	Current Portion Of Deferred Gain CurrentPortionOfDeferredGain	150448	usd
CY2024Q2	dynt	Current Portion Of Deferred Gain CurrentPortionOfDeferredGain	150448	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5896264	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5308519	shares
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000720875
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity File Number EntityFileNumber	0-12697
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	UT
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0398434
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Eagan
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	35072	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3024339	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	302998	usd
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5896264	shares
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	13794996	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	154575	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1619	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	552870	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	328853	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	586762	usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	66029	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	145109	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-667722	usd
CY2024Q2	dynt	Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount PreferredStockDividendInCommonStockIssuedOrToBeIssuedAmount	0	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-687927	usd
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	688200	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	978201	shares
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	513108	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	315075	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1843297	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2272295	usd
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	570783	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	589683	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	5471475	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	5593974	usd
CY2024Q2	us-gaap	Liabilities Liabilities	11780115	usd
CY2024Q2	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3055736	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3444587	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	542754	usd
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-141399	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-533217	usd
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	1200 Trapp Road
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7255563	shares
CY2024Q3	us-gaap	Assets Current AssetsCurrent	9831146	usd
CY2024Q3	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1200	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-402776	usd
CY2024Q3	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	670200	shares
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	50410	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	50410	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	48997	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	513180	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	454390	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	5471475	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	5593974	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	461902	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	530356	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	10557635	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1811941	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1969413	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-106348	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-330654	usd
CY2024Q3	dynt	Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount PreferredStockDividendInCommonStockIssuedOrToBeIssuedAmount	0	usd
CY2024Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-13925	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4616	usd
CY2024Q3	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-231952	usd
CY2024Q3	us-gaap	Nature Of Operations NatureOfOperations	<div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i>Business</i></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">Dynatronics Corporation (the "Company," or "Dynatronics") is a leading medical device company committed to providing high-quality products designed to accelerate optimal health. The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals.</span></span></p> </div>
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i>Use of Estimates</i></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods presented.</span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ materially from those estimates and assumptions.</span></span></p> </div>
CY2024Q3	dynt	Dividend Rate DividendRate	0.08	pure
CY2024Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	337225	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	333949	usd
CY2024Q3	dynt	Rebate Receivable Liability RebateReceivableLiability	264508	usd
CY2024Q2	dynt	Rebate Receivable Liability RebateReceivableLiability	263959	usd
CY2024Q3	us-gaap	Revenues Revenues	7602249	usd
CY2023Q3	us-gaap	Revenues Revenues	9351914	usd
CY2024Q3	ecd	Trd Arr Ind Title TrdArrIndTitle	directors or officers
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001062993-24-019082-index-headers.html	Edgar Link	pending
0001062993-24-019082-index.html	Edgar Link	pending
0001062993-24-019082.txt	Edgar Link	pending
0001062993-24-019082-xbrl.zip	Edgar Link	pending
dynt-20240930.xsd	Edgar Link	pending
exhibit31-1.htm	Edgar Link	pending
exhibit31-2.htm	Edgar Link	pending
exhibit32-1.htm	Edgar Link	pending
exhibit32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dynt-20240930_def.xml	Edgar Link	unprocessable
form10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
dynt-20240930_cal.xml	Edgar Link	unprocessable
dynt-20240930_pre.xml	Edgar Link	unprocessable
dynt-20240930_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DYNT
DYNATRONICS CORP Stock $dynt

2024 Q4 Form 10-Q Financial Statement

#000106299324019082 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYNT DYNATRONICS CORP Stock $dynt

2024 Q4 Form 10-Q Financial Statement

#000106299324019082 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DYNT
DYNATRONICS CORP Stock $dynt